Bravo Multinational Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Bravo Multinational Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2017 | $1.82M | Sep 3, 2019 |
| FY2017 | Dec 31, 2016 | $741.8K | Mar 8, 2019 |
| FY2015 | Dec 31, 2014 | $161.5K | Apr 15, 2016 |
| FY2014 | Dec 31, 2013 | $1.00M | Feb 8, 2016 |
| FY2013 | Dec 31, 2012 | $1.00M | Dec 5, 2014 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2017 | $459.7K | Sep 3, 2019 |
| FY2017 | Dec 31, 2016 | $264.8K | Mar 8, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($253.5K) | Apr 14, 2026 |
| FY2025 | Dec 31, 2024 | ($393.5K) | Apr 14, 2026 |
| FY2024 | Dec 31, 2023 | ($4.85M) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | ($528.1K) | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | ($420.1K) | Mar 6, 2023 |
| FY2021 | Dec 31, 2020 | ($60.47M) | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | ($180.0K) | Mar 2, 2021 |
| FY2019 | Dec 31, 2018 | ($1.40M) | Mar 17, 2020 |
| FY2018 | Dec 31, 2017 | ($1.77M) | Sep 3, 2019 |
| FY2017 | Dec 31, 2016 | ($2.18M) | Mar 8, 2019 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | ($528.1K) | Mar 6, 2023 |
| FY2022 | Dec 31, 2021 | ($527.6K) | Mar 6, 2023 |
| FY2021 | Dec 31, 2020 | ($60.52M) | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | ($178.2K) | Mar 2, 2021 |
| FY2019 | Dec 31, 2018 | ($435.9K) | Mar 17, 2020 |
| FY2018 | Dec 31, 2017 | ($1.45M) | Sep 3, 2019 |
| FY2017 | Dec 31, 2016 | ($1.88M) | Mar 8, 2019 |
| FY2016 | Dec 31, 2015 | ($2.21M) | Jun 23, 2017 |
| FY2015 | Dec 31, 2014 | ($7.02M) | Apr 15, 2016 |
| FY2014 | Dec 31, 2013 | ($7.02M) | Feb 8, 2016 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2016 | $221.7K | Mar 8, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($72.9K) | Apr 14, 2026 |
| FY2025 | Dec 31, 2024 | ($143.2K) | Apr 14, 2026 |
| FY2024 | Dec 31, 2023 | ($165.3K) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | ($53.0K) | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | ($54.1K) | Mar 6, 2023 |
| FY2021 | Dec 31, 2020 | ($76.5K) | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | ($160.3K) | Mar 2, 2021 |
| FY2019 | Dec 31, 2018 | ($58.2K) | Mar 17, 2020 |
| FY2018 | Dec 31, 2017 | ($955.0K) | Sep 3, 2019 |
| FY2017 | Dec 31, 2016 | $281.0K | Mar 8, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2016 | $708 | Mar 8, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $111 | Apr 14, 2026 |
| FY2025 | Dec 31, 2024 | $288 | Apr 14, 2026 |
| FY2024 | Dec 31, 2023 | $1.2K | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $73 | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | $133 | Mar 6, 2023 |
| FY2021 | Dec 31, 2020 | $6.3K | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $16.3K | Mar 2, 2021 |
| FY2019 | Dec 31, 2018 | $10.2K | Mar 17, 2020 |
| FY2018 | Dec 31, 2017 | $474 | Sep 3, 2019 |
| FY2017 | Dec 31, 2016 | $204.1K | Mar 8, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.06M | Apr 14, 2026 |
| FY2025 | Dec 31, 2024 | $802.4K | Apr 14, 2026 |
| FY2024 | Dec 31, 2023 | $409.8K | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $1.77M | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | $1.24M | Mar 6, 2023 |
| FY2021 | Dec 31, 2020 | $825.7K | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $2.10M | Mar 2, 2021 |
| FY2019 | Dec 31, 2018 | $2.08M | Mar 17, 2020 |
| FY2018 | Dec 31, 2017 | $2.18M | Sep 3, 2019 |
| FY2017 | Dec 31, 2016 | $2.91M | Mar 8, 2019 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.06M) | Apr 14, 2026 |
| FY2025 | Dec 31, 2024 | ($802.1K) | Apr 14, 2026 |
| FY2025 | Dec 31, 2023 | ($408.6K) | Apr 14, 2026 |
| FY2024 | Dec 31, 2022 | ($1.77M) | Apr 15, 2025 |
| FY2022 | Dec 31, 2021 | ($1.24M) | Mar 6, 2023 |
| FY2022 | Dec 31, 2020 | ($819.4K) | Mar 6, 2023 |
| FY2020 | Dec 31, 2019 | ($2.09M) | Mar 2, 2021 |
| FY2019 | Dec 31, 2018 | ($2.07M) | Mar 17, 2020 |
| FY2018 | Dec 31, 2017 | ($2.18M) | Sep 3, 2019 |
| FY2017 | Dec 31, 2016 | ($2.71M) | Mar 8, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($96.43M) | Apr 14, 2026 |
| FY2025 | Dec 31, 2024 | ($96.18M) | Apr 14, 2026 |
| FY2024 | Dec 31, 2023 | ($95.79M) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | ($90.94M) | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | ($90.41M) | Mar 6, 2023 |
| FY2021 | Dec 31, 2020 | ($89.99M) | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | ($29.52M) | Mar 2, 2021 |
| FY2019 | Dec 31, 2018 | ($29.34M) | Mar 17, 2020 |
| FY2018 | Dec 31, 2017 | ($27.94M) | Sep 3, 2019 |
| FY2017 | Dec 31, 2016 | ($26.17M) | Mar 8, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $111 | Apr 14, 2026 |
| FY2025 | Dec 31, 2024 | $288 | Apr 14, 2026 |
| FY2024 | Dec 31, 2023 | $1.2K | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $73 | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | $93 | Mar 6, 2023 |
| FY2021 | Dec 31, 2020 | $6.3K | Feb 17, 2022 |
| FY2021 | Dec 31, 2019 | $6.3K | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $50 | Mar 2, 2021 |
| FY2019 | Dec 31, 2017 | $64 | Mar 17, 2020 |
| FY2017 | Dec 31, 2015 | $2.6K | Mar 8, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Apr 14, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Apr 14, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 29, 2024 |
| FY2013 | Dec 31, 2013 | 0 | Dec 5, 2014 |
| FY2013 | Dec 31, 2012 | 0 | Dec 5, 2014 |
| FY2012 | Dec 31, 2011 | 0 | May 6, 2013 |
| FY2011 | Dec 31, 2010 | 0 | Apr 16, 2012 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Apr 14, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Apr 14, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 29, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 47.64M | Apr 14, 2026 |
| FY2025 | Dec 31, 2024 | 47.64M | Apr 14, 2026 |
| FY2024 | Dec 31, 2023 | 47.64M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | 47.64M | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | 47.64M | Mar 6, 2023 |
| FY2021 | Dec 31, 2020 | 47.64M | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | 8.93M | Mar 2, 2021 |
| FY2019 | Dec 31, 2018 | 8.78M | Mar 17, 2020 |
| FY2018 | Dec 31, 2017 | 3.81M | Sep 3, 2019 |
| FY2017 | Dec 31, 2016 | 858,535 | Mar 8, 2019 |